153 related articles for article (PubMed ID: 4023793)
21. Megestrol acetate versus aminoglutethimide for metastatic breast cancer.
Lundgren S; Gundersen S; Klepp R; Lønning PE; Lund E; Kvinnsland S
Breast Cancer Res Treat; 1989 Nov; 14(2):201-6. PubMed ID: 2690972
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
Schmid M; Jakesz R; Samonigg H; Kubista E; Gnant M; Menzel C; Seifert M; Haider K; Taucher S; Mlineritsch B; Steindorfer P; Kwasny W; Stierer M; Tausch C; Fridrik M; Wette V; Steger G; Hausmaninger H
J Clin Oncol; 2003 Mar; 21(6):984-90. PubMed ID: 12637461
[TBL] [Abstract][Full Text] [Related]
23. Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen.
Buzdar AU; Powell KC; Legha SS; Blumenschein GR
Cancer; 1982 Nov; 50(9):1708-12. PubMed ID: 6180820
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
[TBL] [Abstract][Full Text] [Related]
25. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
Brufman G; Isacson R; Haim N; Gez E; Sulkes A
Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
[TBL] [Abstract][Full Text] [Related]
26. Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
Bezwoda WR; Derman DP; Browde S; Goss G; Lange M
S Afr Med J; 1984 Sep; 66(10):372-4. PubMed ID: 6484759
[TBL] [Abstract][Full Text] [Related]
27. Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.
Smith IE; Macaulay V
J R Soc Med; 1985; 78 Suppl 9(Suppl 9):15-7. PubMed ID: 4045913
[No Abstract] [Full Text] [Related]
28. The treatment of metastatic breast cancer with aminoglutethimide.
Kaye SB; Woods RL; Fox RM; Tattersall MH
Aust N Z J Med; 1981 Aug; 11(4):370-4. PubMed ID: 7030292
[TBL] [Abstract][Full Text] [Related]
29. Clinical studies with aminoglutethimide in advanced breast carcinoma.
Harvey HA; Lipton A; Santen RJ
Acta Clin Belg Suppl; 1986; 11():29-40. PubMed ID: 3459321
[No Abstract] [Full Text] [Related]
30. Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen.
Gale KE; Andersen JW; Tormey DC; Mansour EG; Davis TE; Horton J; Wolter JM; Smith TJ; Cummings FJ
Cancer; 1994 Jan; 73(2):354-61. PubMed ID: 8293400
[TBL] [Abstract][Full Text] [Related]
31. Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer.
Smith IE; Harris AL; Stuart-Harris R; Ford HT; Gazet JC; White H; Harmer CL; Carr L; McKinna JA; Morgan M
Br Med J (Clin Res Ed); 1983 May; 286(6378):1615-6. PubMed ID: 6405912
[No Abstract] [Full Text] [Related]
32. Aminoglutethimide (AG) and hydrocortisone (HC) in bone metastases: a retrospective study.
Bonneterre J; Adenis A; Pion JM; Cambier L; Kamus E; Hecquet B
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):693-6. PubMed ID: 8476786
[TBL] [Abstract][Full Text] [Related]
33. [Early results of hormonal treatment of advanced breast cancer with aminoglutethimide].
Pieńkowski T; Zborzil J; Siedlecki P; Flis E; Pałucka A; Pieńkowska F; Rubách M; Piotrowski J
Pol Tyg Lek; 1988 Aug; 43(33):1057-9. PubMed ID: 3072540
[No Abstract] [Full Text] [Related]
34. Aminoglutethimide in the treatment of metastatic breast cancer.
Troner MB
Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
[TBL] [Abstract][Full Text] [Related]
35. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
Konstantinova MM; Gershanovich MA
Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
[TBL] [Abstract][Full Text] [Related]
36. Aminoglutethimide in the management of metastatic breast cancer.
Savaraj N; Troner MB
Med Pediatr Oncol; 1980; 8(3):251-63. PubMed ID: 7464686
[TBL] [Abstract][Full Text] [Related]
37. Aminoglutethimide in postmenopausal breast cancer refractory to multiple hormonal and cytostatic treatments.
Zambetti M; Brambilla C; Tancini G; Bonadonna G
Tumori; 1987 Aug; 73(4):369-73. PubMed ID: 3660475
[TBL] [Abstract][Full Text] [Related]
38. Aminoglutethimide in advanced breast cancer.
Ceci G; Passalacqua R; Bisagni G; Bella M; Cocconi G
Tumori; 1985 Oct; 71(5):483-9. PubMed ID: 2865833
[TBL] [Abstract][Full Text] [Related]
39. Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients.
Lien EA; Johannessen DC; Aakvaag A; Lønning PE
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):541-3. PubMed ID: 1532904
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of metastatic breast cancer with aminoglutethimide after failure of tamoxifen].
Brufman G; Biran S
Harefuah; 1984 Dec; 107(12):377-99. PubMed ID: 6532917
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
